Developer docs
API playgroundTry for free, no card

Search company profiles

Diatron

Full company profile

uuid000cf9d

Namestring
Diatron
Legal namestring
Diatron Medical Instruments Limited
Websiteurl
diatron.com
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Diatron Medical Instruments Limited designs, manufactures, and markets in-vitro diagnostic (IVD) analyzers and reagents, headquartered in Budapest, Hungary. Founded in 1989 by three engineers, the company operates three core product platforms: hematology analyzers (Diatron Aquila, Aquarius 3, Abacus 5/380/Junior 30, and the Abacus Vet5 veterinary system), clinical chemistry analyzers in the Pictus family (P500, P700, and the flagship P780 launched in July 2025), and immunoassay systems (KleeYa chemiluminescent analyzer and GEMINI ELISA workstation). Underlying technologies include fluorescence flow cytometry, microfluidics, bead-based chemiluminescence, and in-house reagent manufacturing conducted at an ISO 13485-certified facility.

The company serves medical laboratories, hospitals, point-of-care facilities, and veterinary clinics across global markets, with operational hubs in Budapest (headquarters) and New Delhi (APAC regional office opened November 2023). Its primary go-to-market is a global network of authorized distributors, supported by a partner extranet portal, regional distributor meetings, and presence at major industry exhibitions including Medica, Medlab Middle East, AACC/ADLM, WHX Labs Dubai, and Medical Fair Thailand. Revenue is generated through hardware sales of analyzers and recurring sales of proprietary reagents, controls, and consumables (with up to 24-month shelf life and 30-60 days on-board stability), supplemented by post-sales technical support, training, and spare-parts services. Diatron is a member of the STRATEC Group, a German-based diagnostic conglomerate, and also operates a wholly owned subsidiary, Mod-n-More Kft, which assembles IVD modules.

Short descriptiontext

Diatron is a Budapest-based IVD manufacturer of hematology, clinical chemistry, and immunoassay analyzers plus proprietary reagents, serving medical labs, hospitals, and veterinary clinics globally through a distributor network as a member of STRATEC Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBudapest, Hungary
HQ citystring
Budapest
HQ countrystring
Hungary
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hematology analyzers, clinical chemistry analyzers, in vitro diagnostics, immunoassay platforms, veterinary diagnostic instruments
Industry4 codes
PRIMARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In Vitro Diagnostic (IVD) Instruments
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Hematology Analyzers
TypeHardware Sales
Description

Sale of hematology analyzers for human and veterinary use, including 3-part and 5-part differential analyzers such as Diatron Aquila, Abacus 5, Abacus 380, Abacus Junior 30, and Abacus Vet5.

diatron.com
2Clinical Chemistry Analyzers
TypeHardware Sales
Description

Sale of clinical chemistry analyzers including Pictus 500, Pictus 700, and P780 systems for human medical, veterinary, drug testing, and food/beverage applications.

diatron.com
3Reagents and Consumables
TypeHardware Sales
Description

Hematology reagents, clinical chemistry reagents, controls, and calibrators specifically designed for Diatron analyzers. Reagents offer up to 24 months shelf life and 30-60 days on-board stability.

diatron.com
4Immunoassay Products
TypeHardware Sales
Description

KleeYa chemiluminescent analyzer and GEMINI ELISA workstation sale, along with associated liquid consumables including reagent cartridges, dispense cartridges, and stackable cuvettes.

diatron.com
5Technical Support and Service
TypeProfessional Services
Description

Post-sales service including product management, technical support, training sessions, and spare parts programs to minimize analyzer downtime for distribution partners.

diatron.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Abacus
Description

Brand for 3 and 5 part hematology analyzers, hematology reagents, and hematology control material

diatron.com
+3 more records
Core offering1 text field

Diatron designs, manufactures, and markets hematology analyzers (3-part and 5-part differential), clinical chemistry analyzers (Pictus family), and chemiluminescent immunoassay platforms (KleeYa, GEMINI) for human medical and veterinary diagnostics. The company also produces the proprietary reagents, controls, and calibrators used with its analyzers and supports customers through a global distributor network and post-sales technical service.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 600+230 tests/h throughput on P780 clinical chemistry system
+4 more records
Product overview1 text field

Diatron develops, manufactures and markets hematology and clinical chemistry products for human medical and veterinary use. The product portfolio is organized into three main categories: (1) Hematology Analyzers — including the Diatron Aquila, Aquarius 3, Abacus 5, Abacus 380, and Abacus Junior 30 for human diagnostics, plus the Abacus Vet5 for veterinary applications; (2) Clinical Chemistry Analyzers — the Pictus family consisting of Pictus 500 (P500), Pictus 700, and the flagship P780, all sharing compatibility with the same reagents, controls, calibrators, consumables and methods; (3) Immunoassay — the KleeYa chemiluminescence platform and GEMINI automated ELISA system. Supporting consumables include hematology reagents and controls, and an extensive clinical chemistry reagent menu covering substrates, enzymes, electrolytes, and specific proteins including HbA1c, ferritin, CRP, and more. The Pictus family analyzers form the core clinical chemistry platform, while the Abacus and Aquila lines form the core hematology platform, with immunoassay products serving as complementary diagnostic capabilities.

Product and service3 records
1Diatron Aquila
CategoryHuman Hematology Analyzers
Description

3-part differential hematology analyzer for complete blood count (CBC) analysis. Supports micro-sampling with capillary blood, optional battery pack for portable use, and features a patented sampling procedure.

2Aquarius 3
CategoryHuman Hematology Analyzers
Description

Hematology analyzer for complete blood count analysis including reliable detection of hematocrit and dehydration assessment.

3Abacus 5
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

Diatron is a member of STRATEC Group, a partnership providing strategic backing and integration within a larger diagnostic solutions ecosystem. Diatron exhibits together with STRATEC at major industry exhibitions including AACC, Medica, and WHX Labs Dubai.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

BioVendor Group is listed as a KleeYa partner, distributing immunoassay products through their CLIA platform offering (clia.biovendor.group).

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Genrui Biotech
TypeEmerging player
Description

Genrui Biotech is a Chinese IVD manufacturer expanding globally in hematology and chemistry analyzers with competitive pricing, increasingly competing with mid-tier European brands like Diatron in APAC and emerging markets.

TypeBroad incumbent
Description

Sysmex is the global market leader in hematology analyzers and reagents, serving hospital and reference labs worldwide. It is the dominant incumbent that Diatron competes against in the 3-part and 5-part differential hematology segments.

TypeDirect peer
Description

ELITechGroup manufactures clinical chemistry analyzers and reagents distributed through dealer networks to mid-tier hospitals and labs — a closely matching peer in scale, distribution model, and chemistry/immunoassay focus.

TypeBroad incumbent
Description

Roche Diagnostics is the largest global IVD player across clinical chemistry, immunoassays, and hematology. While not a direct mid-tier competitor, it sets the benchmark for instrument performance and reagent economics that Diatron's P780 and Abacus lines must compete against.

TypeDirect peer
Description

Mindray is a China-headquartered global IVD and medical device manufacturer with a deeply overlapping hematology, clinical chemistry, and immunoassay analyzer portfolio targeting mid-tier hospital and laboratory customers worldwide — the most direct comparable to Diatron.

TypeDirect peer
Description

Erba Mannheim is a mid-sized IVD manufacturer offering hematology, clinical chemistry, and immunoassay analyzers with proprietary reagents, distributed globally through channel partners — a near-direct peer in scale, portfolio, and business model.

TypeDirect peer
Description

Boule Diagnostics is a Swedish IVD company focused on hematology analyzers and reagents for human and veterinary use, with a comparable distributor-led, mid-tier market positioning to Diatron.

TypeBroad incumbent
Description

Siemens Healthineers offers the Atellica clinical chemistry/immunoassay platform and ADVIA hematology line, serving as a broad incumbent against which Diatron positions its Pictus chemistry and Abacus hematology analyzers.

TypeOthers
Description

BioVendor Group is listed as a Diatron KleeYa immunoassay distributor, making it a channel partner rather than a direct competitor, but it also develops its own CLIA consumables and represents an adjacent immunoassay ecosystem player.

TypeDirect peer
Description

HORIBA Medical manufactures hematology and clinical chemistry analyzers for clinical and veterinary use, with a global distributor model closely mirroring Diatron's go-to-market in mid-tier hospital and lab settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diatron

In Vitro Diagnostic (IVD) Instrumentsdiatron.com

Diatron is a Budapest-based IVD manufacturer of hematology, clinical chemistry, and immunoassay analyzers plus proprietary reagents, serving medical labs, hospitals, and veterinary clinics globally through a distributor network as a member of STRATEC Group.

What Diatron does

Diatron Medical Instruments Limited designs, manufactures, and markets in-vitro diagnostic (IVD) analyzers and reagents, headquartered in Budapest, Hungary. Founded in 1989 by three engineers, the company operates three core product platforms: hematology analyzers (Diatron Aquila, Aquarius 3, Abacus 5/380/Junior 30, and the Abacus Vet5 veterinary system), clinical chemistry analyzers in the Pictus family (P500, P700, and the flagship P780 launched in July 2025), and immunoassay systems (KleeYa chemiluminescent analyzer and GEMINI ELISA workstation). Underlying technologies include fluorescence flow cytometry, microfluidics, bead-based chemiluminescence, and in-house reagent manufacturing conducted at an ISO 13485-certified facility.

The company serves medical laboratories, hospitals, point-of-care facilities, and veterinary clinics across global markets, with operational hubs in Budapest (headquarters) and New Delhi (APAC regional office opened November 2023). Its primary go-to-market is a global network of authorized distributors, supported by a partner extranet portal, regional distributor meetings, and presence at major industry exhibitions including Medica, Medlab Middle East, AACC/ADLM, WHX Labs Dubai, and Medical Fair Thailand. Revenue is generated through hardware sales of analyzers and recurring sales of proprietary reagents, controls, and consumables (with up to 24-month shelf life and 30-60 days on-board stability), supplemented by post-sales technical support, training, and spare-parts services. Diatron is a member of the STRATEC Group, a German-based diagnostic conglomerate, and also operates a wholly owned subsidiary, Mod-n-More Kft, which assembles IVD modules.

Diatron firmographics

Firmographics
Name
Diatron
Legal name
Diatron Medical Instruments Limited
Website
https://diatron.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
101–250 employees
Short description
Diatron is a Budapest-based IVD manufacturer of hematology, clinical chemistry, and immunoassay analyzers plus proprietary reagents, serving medical labs, hospitals, and veterinary clinics globally through a distributor network as a member of STRATEC Group.
Ownership category
akta.pro rank

Diatron industry classification

Industry
Product category
In Vitro Diagnostic (IVD) Instruments
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Hematology analyzers
  • Clinical chemistry analyzers
  • In vitro diagnostics
  • Immunoassay platforms
  • Veterinary diagnostic instruments

Where Diatron is headquartered

Location

Headquarters

HQ city
Budapest
HQ country
Hungary
HQ region
Europe

Offices2 records

Markets served

Diatron business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Hematology Analyzers: Sale of hematology analyzers for human and veterinary use, including 3-part and 5-part differential analyzers such as Diatron Aquila, Abacus 5, Abacus 380, Abacus Junior 30, and Abacus Vet5.
  2. Clinical Chemistry Analyzers: Sale of clinical chemistry analyzers including Pictus 500, Pictus 700, and P780 systems for human medical, veterinary, drug testing, and food/beverage applications.
  3. Reagents and Consumables: Hematology reagents, clinical chemistry reagents, controls, and calibrators specifically designed for Diatron analyzers. Reagents offer up to 24 months shelf life and 30-60 days on-board stability.
  4. Immunoassay Products: KleeYa chemiluminescent analyzer and GEMINI ELISA workstation sale, along with associated liquid consumables including reagent cartridges, dispense cartridges, and stackable cuvettes.
  5. Technical Support and Service: Post-sales service including product management, technical support, training sessions, and spare parts programs to minimize analyzer downtime for distribution partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Diatron product offering

Product offering

Core offering

Diatron designs, manufactures, and markets hematology analyzers (3-part and 5-part differential), clinical chemistry analyzers (Pictus family), and chemiluminescent immunoassay platforms (KleeYa, GEMINI) for human medical and veterinary diagnostics. The company also produces the proprietary reagents, controls, and calibrators used with its analyzers and supports customers through a global distributor network and post-sales technical service.

Product overview

Diatron develops, manufactures and markets hematology and clinical chemistry products for human medical and veterinary use. The product portfolio is organized into three main categories: (1) Hematology Analyzers — including the Diatron Aquila, Aquarius 3, Abacus 5, Abacus 380, and Abacus Junior 30 for human diagnostics, plus the Abacus Vet5 for veterinary applications; (2) Clinical Chemistry Analyzers — the Pictus family consisting of Pictus 500 (P500), Pictus 700, and the flagship P780, all sharing compatibility with the same reagents, controls, calibrators, consumables and methods; (3) Immunoassay — the KleeYa chemiluminescence platform and GEMINI automated ELISA system. Supporting consumables include hematology reagents and controls, and an extensive clinical chemistry reagent menu covering substrates, enzymes, electrolytes, and specific proteins including HbA1c, ferritin, CRP, and more. The Pictus family analyzers form the core clinical chemistry platform, while the Abacus and Aquila lines form the core hematology platform, with immunoassay products serving as complementary diagnostic capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Abacus: Brand for 3 and 5 part hematology analyzers, hematology reagents, and hematology control material
  • Pictus
  • KleeYa
  • GEMINI

Products and services

  • Diatron Aquila 3-part differential hematology analyzer for complete blood count (CBC) analysis. Supports micro-sampling with capillary blood, optional battery pack for portable use, and features a patented sampling procedure.
  • Aquarius 3 Hematology analyzer for complete blood count analysis including reliable detection of hematocrit and dehydration assessment.
  • Abacus 5

Quantifiable outcome

  • Up to 600+230 tests/h throughput on P780 clinical chemistry system
  • +4 more outcomes

Companies that use Diatron

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Diatron technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Diatron partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • STRATEC GroupcoreOthersDiatron is a member of STRATEC Group, a partnership providing strategic backing and integration within a larger diagnostic solutions ecosystem. Diatron exhibits together with STRATEC at major industry exhibitions including AACC, Medica, and WHX Labs Dubai.
  • BioVendor GroupminorChannel Partner/ Reseller/ DistributorBioVendor Group is listed as a KleeYa partner, distributing immunoassay products through their CLIA platform offering (clia.biovendor.group).

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Diatron competitors and assessment

Company assessment

Emerging players

  • Genrui Biotech: Genrui Biotech is a Chinese IVD manufacturer expanding globally in hematology and chemistry analyzers with competitive pricing, increasingly competing with mid-tier European brands like Diatron in APAC and emerging markets.

Broad incumbents

  • Sysmex: Sysmex is the global market leader in hematology analyzers and reagents, serving hospital and reference labs worldwide. It is the dominant incumbent that Diatron competes against in the 3-part and 5-part differential hematology segments.
  • Roche Diagnostics: Roche Diagnostics is the largest global IVD player across clinical chemistry, immunoassays, and hematology. While not a direct mid-tier competitor, it sets the benchmark for instrument performance and reagent economics that Diatron's P780 and Abacus lines must compete against.
  • Siemens Healthineers: Siemens Healthineers offers the Atellica clinical chemistry/immunoassay platform and ADVIA hematology line, serving as a broad incumbent against which Diatron positions its Pictus chemistry and Abacus hematology analyzers.

Direct peers

  • ELITechGroup: ELITechGroup manufactures clinical chemistry analyzers and reagents distributed through dealer networks to mid-tier hospitals and labs — a closely matching peer in scale, distribution model, and chemistry/immunoassay focus.
  • Mindray: Mindray is a China-headquartered global IVD and medical device manufacturer with a deeply overlapping hematology, clinical chemistry, and immunoassay analyzer portfolio targeting mid-tier hospital and laboratory customers worldwide — the most direct comparable to Diatron.
  • Erba Mannheim: Erba Mannheim is a mid-sized IVD manufacturer offering hematology, clinical chemistry, and immunoassay analyzers with proprietary reagents, distributed globally through channel partners — a near-direct peer in scale, portfolio, and business model.
  • Boule Diagnostics: Boule Diagnostics is a Swedish IVD company focused on hematology analyzers and reagents for human and veterinary use, with a comparable distributor-led, mid-tier market positioning to Diatron.
  • HORIBA Medical: HORIBA Medical manufactures hematology and clinical chemistry analyzers for clinical and veterinary use, with a global distributor model closely mirroring Diatron's go-to-market in mid-tier hospital and lab settings.

Others

  • BioVendor Group: BioVendor Group is listed as a Diatron KleeYa immunoassay distributor, making it a channel partner rather than a direct competitor, but it also develops its own CLIA consumables and represents an adjacent immunoassay ecosystem player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Diatron social profiles

Digital presence

Diatron compliance and trust

Trust signal

Compliance4 records

Diatron financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diatron leadership team

Management profile

Number of profiles

Profiles6 records

Diatron subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Diatron funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diatron M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diatron

What does Diatron do?

Diatron designs, manufactures, and markets hematology analyzers (3-part and 5-part differential), clinical chemistry analyzers (Pictus family), and chemiluminescent immunoassay platforms (KleeYa, GEMINI) for human medical and veterinary diagnostics. The company also produces the proprietary reagents, controls, and calibrators used with its analyzers and supports customers through a global distributor network and post-sales technical service.

Is Diatron a public or private company?

Diatron is a private company. It is classified as corporate owned and is currently operating.

When was Diatron founded?

Diatron was founded in 1989. It employs 101 to 250 people.

Where is Diatron based?

Diatron is headquartered in Budapest, Hungary, in the Europe region.

How does Diatron make money?

Five revenue lines are on record. Hematology Analyzers are the primary driver. The others are clinical Chemistry Analyzers, reagents and Consumables, immunoassay Products and technical Support and Service.

Who are Diatron's main competitors?

Genrui Biotech is listed as an emerging player. Broad incumbents are Sysmex, Roche Diagnostics and Siemens Healthineers. Direct peers are ELITechGroup, Mindray, Erba Mannheim, Boule Diagnostics and HORIBA Medical. BioVendor Group is listed as an others.

Does Diatron have an API?

No public API is recorded for Diatron.

What industry is Diatron in?

Diatron's product category is In Vitro Diagnostic (IVD) Instruments. Its primary akta.pro industry code is HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing), with a secondary code of HLAHAAAA, Clinical Chemistry & Immunoassay Systems. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comWhy is Stratec stock climbing today?Stratec SE shares rose 5% to €28.60, hitting a 52-week high, after the company reported nine-month 2026 results. Adjusted EBIT margin improved to 13.4% and operating cash flow turned positive, while the Diatron divestiture removes an expected €10 million drag. Analyst Berenberg raised its price target to €39.News-MedicalDiatron introduces advanced RUO indices on its Aquila, Aquarius 3, Abacus 5 analyzersDiatron added six research-use-only hematological indices to its Aquila, Aquarius 3, and Abacus 5 analyzers. The indices include NLR, PLR, MLR, Mentzer Index, RDWI, and Green & King Index, automatically calculated from routine CBCs without extra costs. They are not available in the USA.FortunebusinessinsightsVeterinary Chemistry Analyzer Market Size, ShareThe global veterinary chemistry analyzer market was valued at USD 3.41 billion in 2025 and is projected to reach USD 5.45 billion by 2034, growing at a CAGR of 5.2%, driven by rising chronic disease prevalence in animals, increased pet adoption, and technological innovations by key players. Key industry participants including IDEXX Laboratories, Zoetis Services LLC, BIONOTE, Diatron, and Chengdu Seamaty Technology have been actively launching new analyzers and expanding their product portfolios to capture market share. The market faces challenges from high operational costs, workflow integration burdens, and lack of standardization, while North America accounts for the largest regional share at approximately 34.1% of global revenues.The Times of IndiaOur investment plan involves creating a Centre of Excellence in India: Peter Zsoka, Director Diatron, ET HealthWorldDiatron plans to establish a Centre of Excellence in India, producing its first 'Made in India' reagents next year. The company aims to eventually manufacture analyzers in India and launch two new products, a haematology and clinical chemistry analyzer, in collaboration with Indian partners.PR NewswireGlobal Hematology Testing Market (2021 to 2027) - Featuring Abbott, Boule Diagnostics and Diatron Among OthersResearchAndMarkets published a global hematology testing market report estimating the market will grow from USD 3.38 billion in 2021 to USD 4.41 billion by 2027 at a 4.51% CAGR, driven by rising disease prevalence, technological advancements, and increased telehealth adoption.News-MedicalDiatron to exhibit new 5-part differential hematology analyzer with reticulocytes at Medica 2019Diatron will exhibit its new Aquila 5D retics hematology analyzer at Medica 2019 in Dusseldorf, Germany, from 18-21 November. The compact, 5-part differential analyzer with reticulocytes offers 80 tests per hour, low reagent consumption, and a continuous loading autoloader.GlobeNewswireDGAP-News: STRATEC - Results for 1st Half of 2016 and new Financial GuidanceSTRATEC Biomedical reported first-half 2016 sales of EUR 78.0 million, up 11.5% year-on-year, with EBIT margin at 16.2%. The company also announced acquisitions of Diatron and Sony DADC BioSciences, and provided a 2016 sales forecast of EUR 175-182 million.GlobeNewswireDGAP-News: STRATEC reports on first three months of 2016 (news with additional features)STRATEC Biomedical reported Q1 2016 sales of EUR 31.2 million, down 9.6% year-on-year, with EBIT of EUR 4.5 million and net income of EUR 3.4 million. The company acquired Diatron on March 31, 2016, and proposed a dividend of EUR 0.75 per share for the 2015 financial year.